27 results
Suspected ACS - OMI vs STEMI - Differential Algorithm

The name STEMI cognitively inspires EPs to fail
Suspected ACS - OMI ... vs STEMI - Differential ... Algorithm The ... EMNews #ACS #OMI ... #Algorithm #cardiology
Schema for documenting a type 1 MI, type 2 MI, or non-MI troponin elevation based on
, type 2 MI, or ... non-MI troponin ... elevation based on clinical ... TypeI #TypeII #MI ... Billing #Guideline #NSTEMI
DETROIT CARDIOGENIC SHOCK INITIATIVE ALGORITHM

INCLUSION CRITERIA
Acute Myocardial Infarction
 Ischemic Symptoms
 EKG and/or biomarker evidence of AMI
SHOCK INITIATIVE ALGORITHM ... biomarker evidence of AMI ... (STEMI or NSTEMI ... Cardiogenic #Shock #Algorithm
Differentiating type-I vs. type-II MI

Sorting this out is difficult, often relying heavily on clinical judgement.

A key
type-I vs. type-II MI ... relying heavily on clinical ... The table below ... Type2 #Definition #NSTEMI ... #Comparison #Table
Left Main Coronary Artery Thrombus seen on Angiography

“Mother of all coronary thrombi”.  55 year old
Anterior wall STEMI ... established, but died on table ... Angiogram #CathLab #clinical
Summary of types of haemolytic anaemia. Visit gramproject.com for more medical diagrams, tables and flowcharts for
medical diagrams, tables ... #diagnosis #clinical ... #differential #algorithm
Summary flowchart for investigating suspected pulmonary embolism. Visit gramproject.com for more medical diagrams, tables and flowcharts
medical diagrams, tables ... #diagnosis #algorithm ... em #pulmonary #clinical
Fatigue and IBD Algorithm
 • 40-50% patients have fatigue despite clinical remission
 • Risk factors: BMI,
Fatigue and IBD Algorithm ... fatigue despite clinical ... Risk factors: BMI ... modifications Algorithm ... #Fatigue #IBD #Algorithm
IDSA Algorithm for the Initial Management of Fever and Neutropenia

LOW RISK
 • Antidpated neutropenia < 7
IDSA Algorithm for ... neutropenia < 7 days and clinically ... stable and no medical ... >7 days or • Clinically ... #fever #IDSA #Algorithm
Myositis Specific Antibodies (MSAs)

Dermatomyositis: MDA5, TIF1y, NXP2, Mi-2, SAE
Anti-Synthetase Syndrome: Jo-1, PL7, PL12, EJ, OJ
Immune Mediated
, TIF1y, NXP2, Mi ... Antibodies #MSAs #clinical ... #rheumatology #table